Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taj Mohammad

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
RSC Advances|May 6, 2022
Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3Rashmi Dahiya, Taj Mohammad, Preeti Gupta, et al.
Plos One|January 24, 2025
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeuticsMd Nayab Sulaimani, Shazia Ahmed, Farah Anjum, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|August 8, 2024
Response to Recombinant Human Growth Hormone (rhGH) Therapy in Children with Growth Hormone DeficiencyMaira Riaz, Mohsina Noor Ibrahim, Versha Rani Rai, et al.
Molecular Diversity|November 25, 2025
Computational identification of Cucurbitacin S and Kammogenin as bioactive focal adhesion kinase 2 inhibitors for targeted cancer therapySalem Hussain Alharethi, Fatma A M Mohamed, Saleha Y M Alakilli, et al.
Omics : a Journal of Integrative Biology|October 10, 2024
Phytochemicals Neogitogenin and Samogenin Hold Potentials for Hepatocyte Growth Factor Receptor-Targeted Cancer TreatmentAbdelbaset Mohamed Elasbali, Farah Anjum, Bodour Ali Al-Ghabban, et al.
Journal of Biomolecular Structure & Dynamics|July 23, 2022
Fructosylation of human insulin causes AGEs formation, structural perturbations and morphological changes: an <i>in silico</i> and multispectroscopic studyAli Raza, Riaz Mahmood, Safia Habib, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 29, 2019
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapyPreeti Gupta, Taj Mohammad, Parvez Khan, et al.
Protein and Peptide Letters|February 10, 2022
PyPAn: An Automated Graphical User Interface for Protein Sequence and Structure AnalysesYash Mathur, Taj Mohammad, Farah Anjum, et al.
Molecules (Basel, Switzerland)|December 19, 2019
Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer TherapyTaj Mohammad, Sagar Batra, Rashmi Dahiya, et al.
Biotechnology Advances|July 10, 2025
Current advancement in AI-integrated drug discovery: Methods and applicationsYash Mathur, Arunabh Choudhury, Sneh Prabha, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
RSC Advances|May 6, 2022
Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3Rashmi Dahiya, Taj Mohammad, Preeti Gupta, et al.
Plos One|January 24, 2025
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeuticsMd Nayab Sulaimani, Shazia Ahmed, Farah Anjum, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|August 8, 2024
Response to Recombinant Human Growth Hormone (rhGH) Therapy in Children with Growth Hormone DeficiencyMaira Riaz, Mohsina Noor Ibrahim, Versha Rani Rai, et al.
Molecular Diversity|November 25, 2025
Computational identification of Cucurbitacin S and Kammogenin as bioactive focal adhesion kinase 2 inhibitors for targeted cancer therapySalem Hussain Alharethi, Fatma A M Mohamed, Saleha Y M Alakilli, et al.
Omics : a Journal of Integrative Biology|October 10, 2024
Phytochemicals Neogitogenin and Samogenin Hold Potentials for Hepatocyte Growth Factor Receptor-Targeted Cancer TreatmentAbdelbaset Mohamed Elasbali, Farah Anjum, Bodour Ali Al-Ghabban, et al.
Journal of Biomolecular Structure & Dynamics|July 23, 2022
Fructosylation of human insulin causes AGEs formation, structural perturbations and morphological changes: an <i>in silico</i> and multispectroscopic studyAli Raza, Riaz Mahmood, Safia Habib, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 29, 2019
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapyPreeti Gupta, Taj Mohammad, Parvez Khan, et al.
Protein and Peptide Letters|February 10, 2022
PyPAn: An Automated Graphical User Interface for Protein Sequence and Structure AnalysesYash Mathur, Taj Mohammad, Farah Anjum, et al.
Molecules (Basel, Switzerland)|December 19, 2019
Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer TherapyTaj Mohammad, Sagar Batra, Rashmi Dahiya, et al.
Biotechnology Advances|July 10, 2025
Current advancement in AI-integrated drug discovery: Methods and applicationsYash Mathur, Arunabh Choudhury, Sneh Prabha, et al.
Pageof 15